Navigation Links
LifeCare Holdings, Inc. Announces Third Quarter Results
Date:11/14/2007

ite. Many of the factors that will determine the Company's future results are beyond the ability of management to control or predict. As a result, you should not place undue reliance on forward-looking statements, which reflect management's views only as the date hereof. The Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements whether as a result of new information, future events or otherwise.

Non-GAAP Financial Measures

Credit Agreement EBITDA is used in the calculations of the interest coverage and leverage ratios that are included in the covenants contained in our existing senior secured credit agreement. Credit Agreement EBITDA is not a measure of financial performance computed in accordance with GAAP and should not be considered in isolation or as a substitute for operating income, net income, cash flows from operations or other statement of operations or cash flow data prepared in conformity with GAAP, or as measures of profitability or liquidity. In addition the calculation of Credit Agreement EBITDA is susceptible to varying interpretations and calculation, and the amounts presented may not be comparable to similarly titled measures of other companies. Credit Agreement EBITDA may not be indicative of historical operating results, and we do not mean for it to be predictive of future results of operations or cash flows. For the trailing 12-month period ended September 30, 2007, Credit Agreement EBITDA was $46.0 million, including the $6.0 million cure discussed previously.

LifeCare, based in Plano, Texas, operates 19 long term acute care hospitals located in nine states. Long term acute care hospitals specialize in the treatment of medically complex patients who typically require extended hospitalization. For more information on LifeCare, visit our website at http://www.lifecare-hospitals.com.

Sche
'/>"/>

SOURCE LifeCare Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine news :

1. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
2. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
3. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
4. Platinum Underwriters Holdings, Ltd. to Report Third Quarter 2007 Results on October 23, 2007
5. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
6. NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call
7. China Shenghuo Pharmaceutical Holdings, Inc. Opens Showcase 12Ways(R) Chinese Herbal Beauty Salon in October
8. NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results
9. Duane Reade Holdings, Inc. to Report Third Quarter 2007 Financial Results
10. China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline
11. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2008)... PHOENIX, May 22 /PRNewswire/ -- TriWest Heal...Telly Awards in the 28th Annual Telly Awards,compe...r the visual arts,community., The awards recogniz...ideo as an effective medium to reach military serv...sources and clinical support tools., "At TriWest,...
(Date:5/22/2008)... IRVINE, Calif., May 22 /PRNewswire/ -- Accen...een formally accepted into Sun,s Authorized,Subcon...Delivery Workforce,to provide improved integration...w relationship, Accenx Technologies will see subst...nt roster, develop a closer working,relationship w...
(Date:5/22/2008)... , LOS ANGELES, May 22 /PRNewswire-USNewswire/ -...used on prevention and recovery from Autism,ADHD ... of the organization,through three major steps:, ...ave joined the Board,of Directors., Ms. McCarthy ...other,who recovered her son Evan from autism. Her ...
(Date:5/22/2008)... First Product That Gives Consumers an All-Natura...robiotics & Prebiotic Fiber, JERICHO, N.Y., May 2...ottage cheese with more healthy benefits hits supe...e Health Cottage Cheese with Pro-Active,Nutrients....ed All-Natural,cottage cheese product, Friendship ...
Breaking Medicine News(10 mins):Health News:TriWest Receives National Awards for Innovative Video Communications to Military Community 2Health News:TriWest Receives National Awards for Innovative Video Communications to Military Community 3Health News:Accenx Technologies Joins Sun's Authorized Subcontractor Program 2Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 2Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 3Health News:New Friendship Cottage Cheese Boosts Digestive & Bone Health 2Health News:New Friendship Cottage Cheese Boosts Digestive & Bone Health 3
...s among children that were known until now were ch...y recently, researchers and neurologists have foun... ailments //in newborns that often go unnoticed. A...na Ferriero, Chief of Neurology at the University ...
...on University School of Medicine have tried a new ...urpura(TPP), which has offered great hope. TPP is ...s in the blood clotting system is missing. This pr...ne of the other clotting proteins sticks to itself...
...e looking up for a long time, like painting, plumb...However, a new product called Necprotech developed...p// reduce neck strain by a third. The product was... clinging to a rock wall look easy, but a slip fiv...
...nce of keeping a clean environment and self to le...us are not aware that just a simple habit of hand ...ctions. Everyday life does not involve// many acti...m heavy house work and gardening, and this is prob...
Other Medicine News:Health News:Stroke also in list of common childhood ailments 2
(Date:5/21/2008)...rom CHARM Study in Remission at One Year ...T PARK, Ill., May 21 /- Res...ott pivotal studies, CHARM and GAIN,demonstrate t...ted with,HUMIRA(R) (adalimumab) achieved long-term...ively, according to data presentations today at Di...
(Date:5/21/2008)...ighlight Watson,s commitment to urology - ..., Fla., May 21 /- Watson Ph...alty pharmaceutical company, announced,today that ... 3 products at,the American Urological Association... safety trial involving silodosin, an investigatio...
(Date:5/21/2008).../ -- Alba Therapeutics Corporation,announced today...presented,in the Clinical Advances in Celiac Disea...ting in San Diego, California. Results of the rand... larazotide acetate for the,prevention of celiac d...subjects in remission(1) were presented by Daniel ...
(Date:5/21/2008)...long-term survivors validate Jennerex ...SCO and YONGIN-SI, South Korea, May 21 /PRNewswire... Ontario), and its South,Korean partner Green Cros...al results from its first-in-class lead product JX...Oncology. The majority of these end- stage,patient...
Breaking Medicine Technology:Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 2Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 3Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 4Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 5Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 6Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 7Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 2Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 3Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 4Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 5Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 6Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 2Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 3Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 4Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 5Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 2Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 3Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 4Neurobiological Technologies Announces Pricing of Its 2460 Million Common Stock Offering 1579 1Neurobiological Technologies Announces Pricing of Its 2460 Million Common Stock Offering 1579 2Younger Adults Increasingly Treated for Heart Disease related Conditions 694 1Younger Adults Increasingly Treated for Heart Disease related Conditions 694 2Younger Adults Increasingly Treated for Heart Disease related Conditions 694 3Younger Adults Increasingly Treated for Heart Disease related Conditions 694 4P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 1P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 2P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 3P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 4P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 5P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 6P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 7P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 8P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 9P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 10P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 11P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 12P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 13P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 14P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 15P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 16Elan Pharmaceuticals Inc Licenses Software and Databases From GeneGo 4948 1
... /PRNewswire-FirstCall/ --,Alfacell Corporation,s ...s a potent payload in antibody conjugates for canc... Handbook of Therapeutic,Antibodies. , In a chapte...ybak, Ph.D. summarizes preclinical research indica...improves in a number of tumor,models, including no...
...PRNewswire/ -- Treatment of,coronary artery diseas...ient setting, according to a study published today...pitalization rates for heart attacks (acute myocar...to 2005, possibly due,to broader use of preventive...ell as declines in risk factors like smoking. , Th...
Other Medicine Technology:Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 2Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 3Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 4Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 2Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 3
...r transfusion needs. A recognized leader in autotr...ay to add the safety of microfiltration for a vari...ve or postoperative applications, autologous or ho...rovides both convenience and versatility in the re...
This high technology cast plaster cutter saw is very easy and comfortable to use.
Designed to reduce noise to a minimum results in less emotional trauma for patients and less hearing trauma for the clinician. The innovative motor plus saw design delivers high power in a smaller, l
The True/Fix Cannulated Bone Screw System contains 7.0mm large cannulated bone screws and 3.5mm cortical and 4.0mm cannulated cancellous bone screws.
Medicine Products: